The Foundation continues to fund ARSACS research projects in 2016, a maximum of $100,000 per year with a possiblilty of renewal for a second year. If you are interested in the subject, please send your completed application form now. The deadline is May 20, 2016.Read More
The "Dîner des Producteurs" held in Montreal on December 3 raised the net sum of $729,000 for ARSACS research. The Ataxia Charlevoix-Saguenay Foundation would like to thank the attendees and donors for their support and generosityRead More
A conference call with a pharmaceutical company is scheduled for January 12th to discuss the possibility of inserting a compound on ARSACS mice. More details to come.
Care4Rare is a research project to identify therapeutic leads for rare diseases such as ARSACS. The Foundation is financing the ARSACS portion under the leadership of Dr. Kym Boycott and Dr. Alex MacKenzie from the Children Hospital of Eastern Ontario. Year 2 Summary
The Foundation is looking for researchers/partners interested in participating in the 2016 E-Rare-3 competition. The pre-registration deadline for proposals is February 1,2016. For more information please see E-Rare-3 Call for Proposals
The phase II chronic study on the ARSACS mouse with respect to a compound is now at a wrap up stage. The conclusions of the study can be summarized by a problematic delivery of the compound. Therefore, the study will no be pursued further.